Formulation and immunological evaluation of a trivalent vaccine comprising emulsified submicron particles and inactivated virions of H5N1/EV71/JEV - Wikidata - wikimedia - TriplyDB

Formulation and immunological evaluation of a trivalent vaccine comprising emulsified submicron particles and inactivated virions of H5N1/EV71/JEV

Formulation and immunological evaluation of a trivalent vaccine comprising emulsified submicron particles and inactivated virions of H5N1/EV71/JEV

http://www.wikidata.org/entity/Q28660283

about

Immunogenicity studies of bivalent inactivated virions of EV71/CVA16 formulated with submicron emulsion systems.

P2860

Q33809953-42F75703-EDF5-40CF-8CBF-94A5A4C3E473

P2860

Formulation and immunological evaluation of a trivalent vaccine comprising emulsified submicron particles and inactivated virions of H5N1/EV71/JEV

http://www.wikidata.org/entity/Q28660283

description

2013 nî lūn-bûn

@nan

2013 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Formulation and immunological ...... vated virions of H5N1/EV71/JEV

@ast

Formulation and immunological ...... vated virions of H5N1/EV71/JEV

@en

Formulation and immunological ...... vated virions of H5N1/EV71/JEV

@nl

type

label

Formulation and immunological ...... vated virions of H5N1/EV71/JEV

@ast

Formulation and immunological ...... vated virions of H5N1/EV71/JEV

@en

Formulation and immunological ...... vated virions of H5N1/EV71/JEV

@nl

prefLabel

Formulation and immunological ...... vated virions of H5N1/EV71/JEV

@ast

Formulation and immunological ...... vated virions of H5N1/EV71/JEV

@en

Formulation and immunological ...... vated virions of H5N1/EV71/JEV

@nl

P1433

Q28660283-ED53D7E6-A659-458E-9C2A-51032DF8DB6C

P1476

Q28660283-EE0D9CF9-3A2D-4950-85B6-B39E14546B9D

P2093

Q28660283-35A29AE4-FF61-4EB6-8A80-B07246903710

Q28660283-6C5C4474-B065-4951-9FC6-86DB32D09477

Q28660283-79780C8B-B128-4A2A-A422-969D0100362A

Q28660283-79BCF00A-11BE-4303-BE2C-136FC8A864DA

Q28660283-7C16196C-C367-4E06-B095-44606C2222D3

Q28660283-9B25391C-64E7-47CC-B21E-8677E91335CC

Q28660283-AE4020B8-93DD-4E33-878F-FBC94C3CA73C

Q28660283-B0B3637D-D57C-46DB-8FBB-DD0C66A7DF9A

Q28660283-C2E9ADBC-6EBD-41C0-B162-1DDE36E49470

Q28660283-C9FE5514-E437-4E03-9B72-6C37FD49D8C1

P2860

Q28660283-34CF9065-F473-41A4-8EB0-F095E94C3667

Q28660283-3C2A09FC-4809-47E5-AEFB-3AAA7BF90A41

Q28660283-487368FD-E21C-4E72-BE9A-257E1FE28E42

Q28660283-7BAEF1F7-7581-434A-B0F4-406C63F59FAE

Q28660283-852138E5-F44B-4420-9D4B-CF6421201729

Q28660283-8EA0B6EF-A24C-4220-BDB3-B131B193F6BC

Q28660283-8FA6619D-F68F-437B-8287-6AEFACE5D1E7

Q28660283-942847F7-E26D-453D-859B-18540858FD28

Q28660283-AFE28213-0B8C-4454-ADD3-38C9F1D0033F

Q28660283-BB6B5857-0162-4D0D-B74B-F35DC1AC316D

P304

Q28660283-1AB36D78-5094-48B2-A06A-B601D6E56342

P31

Q28660283-FF2CF691-8457-4DE4-90A6-4C87CD3E35C4

P356

Q28660283-3098FF5C-C9E0-436B-8B40-67E5AF430E47

P407

Q28660283-7FE8A16D-A400-4BDB-AA58-6C5560CFBC50

P433

Q28660283-5114EB81-90E5-4BFC-A3DA-39B38E5804AA

P478

Q28660283-4F72F8DB-3EB6-4A22-85AE-38BAC94D9772

P50

Q28660283-97BE8CAD-F4EE-4BF4-92E3-782D58495184

Q28660283-F4A1CB0A-10AC-4956-AB6C-4601CE027748

P577

Q28660283-3808BA9A-470B-4091-9B5F-9452A309949E

P5875

Q28660283-A858D53D-73C6-4A0E-B6DE-AC18E60AAE71

P698

Q28660283-6DAE1F59-A448-47AA-9CC8-A68114C524C5

P921

Q28660283-8BBBCF87-3814-4C8B-9400-3E2DB11E9F7B

P932

Q28660283-AE3F0637-EAA6-4DBB-A5F0-4D31AED7F835

P356

P1433

Human Vaccines & Immunotherapeutics

P1476

Formulation and immunological ...... vated virions of H5N1/EV71/JEV

@en

P2093

Ai-Hsiang Chou

http://www.w3.org/2001/XMLSchema#string

Alan Yung-Chih Hu

http://www.w3.org/2001/XMLSchema#string

Chien-Chun Liao

http://www.w3.org/2001/XMLSchema#string

Chih-Wei Lin

http://www.w3.org/2001/XMLSchema#string

Ching-Yun Chang

http://www.w3.org/2001/XMLSchema#string

Jui-Yuan Chang

http://www.w3.org/2001/XMLSchema#string

Pele Chong

http://www.w3.org/2001/XMLSchema#string

Shih-Chang Lin

http://www.w3.org/2001/XMLSchema#string

Suh-Chin Wu

http://www.w3.org/2001/XMLSchema#string

Tsung-Chun Lu

http://www.w3.org/2001/XMLSchema#string

P2860

Production of EV71 vaccine candidates

General recommendations on immunization --- recommendations of the Advisory Committee on Immunization Practices (ACIP)

Emulsified nanoparticles containing inactivated influenza virus and CpG oligodeoxynucleotides critically influences the host immune responses in mice

Enhancement of potent antibody and T-cell responses by a single-dose, novel nanoemulsion-formulated pandemic influenza vaccine.

Preexisting influenza-specific CD4+ T cells correlate with disease protection against influenza challenge in humans.

Pilot scale production of highly efficacious and stable enterovirus 71 vaccine candidates.

Enzymatic stability and immunoregulatory efficacy of a synthetic indolicidin analogue with regular enantiomeric sequence.

Purification and characterization of enterovirus 71 viral particles produced from vero cells grown in a serum-free microcarrier bioreactor system.

Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010.

Adjuvanticity of the oil-in-water emulsion MF59 is independent of Nlrp3 inflammasome but requires the adaptor protein MyD88

P304

2378-2385

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4161/HV.25639

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P50

P577

2013-07-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

248383884

http://www.w3.org/2001/XMLSchema#string

P698

23838466

http://www.w3.org/2001/XMLSchema#string

P921

P932

3981847

http://www.w3.org/2001/XMLSchema#string